Trabecular Micro-Bypass Stent Use in Necrotizing Scleritis.

J Glaucoma

Department of Ophthalmology, University of Alberta, Edmonton, AB, Canada.

Published: February 2017

Purpose: In this case report, we describe the successful implantation of multiple trabecular micro-bypass iStents in a patient with necrotizing scleritis.

Design: The study design is a case report.

Participants: The participant was a patient who underwent multiple micro-bypass iStent surgery.

Methods: A 71-year-old man with primary open-angle glaucoma, diagnosed with necrotizing scleritis and treated with steroids consequently resulting in significantly elevated intraocular pressure in the right eye.

Results: Following uncomplicated surgery, IOP was reduced from 42 to 12 mm Hg 18 months after surgery on 2 drops and prednisone 40 mg daily CONCLUSIONS:: iStents may be considered as a possible intervention to lower IOP in patients with necrotizing scleritis in whom traditional glaucoma surgery is challenging or contraindicated.

Download full-text PDF

Source
http://dx.doi.org/10.1097/IJG.0000000000000602DOI Listing

Publication Analysis

Top Keywords

necrotizing scleritis
12
trabecular micro-bypass
8
micro-bypass stent
4
necrotizing
4
stent necrotizing
4
scleritis purpose
4
purpose case
4
case report
4
report describe
4
describe successful
4

Similar Publications

Purpose: To study clinical features, anatomical and visual outcomes in eyes having rhegmatogenous retinal detachment (RD) as the presenting feature of acute retinal necrosis (ARN).

Materials And Methods: We conducted a retrospective cohort study of patients with ARN (active/healed) and concomitant RD at the presenting visit.

Results: The median age of patients was 36 years, with a male preponderance (9:1).

View Article and Find Full Text PDF

We present a patient with isolated autoimmune anterior scleritis and a patient with nonspecific orbital inflammation (NSOI). Both patients were treated with systemic corticosteroids during multiple recurrences, with the addition of various disease-modifying antirheumatic drugs (DMARDs), including biologics, in the case of scleritis, resulting in complications and local adverse events. Both patients were subsequently effectively managed using Janus kinase inhibitors (JAK-i), specifically baricitinib and tofacitinib without relapses of inflammation during the follow-up of more than one year.

View Article and Find Full Text PDF

Wide-field fluorescein angiography findings in active anterior scleritis.

J Ophthalmic Inflamm Infect

December 2024

Inflammatory Eye Disease Clinic, Asociación para Evitar la Ceguera en México, Vicente Garcia Torres No. 46 Coyoacán, Mexico City, 04030, Mexico.

Objective: Describe the proportion of patients with wide-field fluorescein angiographic (WFFA) findings in patients with active anterior scleritis.

Methods: An observational, descriptive, cross-sectional study of the WFFA findings of patients with active anterior scleritis including nodular, diffuse, or necrotizing involvement was performed. Studies were performed with the Heidelberg Spectralis module (102º).

View Article and Find Full Text PDF

Developing the biomarker panels and drugs by proteomic analysis for autoimmune uveitis and posterior scleritis.

iScience

December 2024

Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin, China.

Autoimmune uveitis and posterior scleritis are ocular diseases caused by immune dysregulation. Their pathogenesis remains elusive, and delayed diagnosis can exacerbate vision loss. Our study analyzed proteomic profiles of 190 patients with Behcet's disease uveitis, posterior scleritis, and Vogt-Koyanagi-Harada syndrome.

View Article and Find Full Text PDF

Pseudomonas-induced scleritis mimicking autoimmune necrotizing scleritis. A case report.

Arch Soc Esp Oftalmol (Engl Ed)

December 2024

Departamento de Uveítis e Inmunología Ocular, Instituto de Oftalmología FAP Conde de Valenciana, Ciudad de México, Mexico. Electronic address:

To report a case of spontaneous-onset unilateral scleritis and keratitis due to Pseudomonas aeruginosa in a patient with systemic lupus erythematosus who partially responded to antibiotic therapy and achieved complete resolution after IV immunotherapy. A 30-year-old woman with a past medical history of hypothyroidism and systemic lupus erythematosus and on irregular therapy presented with a long-history of thinning of the sclera and cornea refractory to antibiotic therapy despite a positive culture for P. aeruginosa, which eventually resolved with the implementation of immunotherapy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!